We are live on ! Find out more
RG

Rathbones Group Portfolio holdings

AUM $25B
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+6.02%
1 Year Est. Return
+18.87%
3 Year Est. Return
+73.23%
5 Year Est. Return
+90.52%
10 Year Est. Return
+458.69%
AUM
$2.3B
AUM Growth
+$52.6M
Cap. Flow
-$58.7M
Cap. Flow %
-2.56%
Top 10 Hldgs %
28.02%
Holding
334
New
16
Increased
94
Reduced
96
Closed
16

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$5.77M
2
MNST icon
Monster Beverage
MNST
+$4.48M
3
FRC
First Republic Bank
FRC
+$4.24M
4
PFE icon
Pfizer
PFE
+$3.36M
5
WEC icon
WEC Energy
WEC
+$3.26M

Top Sells

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$24.6M
2
EFX icon
Equifax
EFX
+$19.5M
3
ULTA icon
Ulta Beauty
ULTA
+$18.4M
4
ORLY icon
O'Reilly Automotive
ORLY
+$14.7M
5
JNJ icon
Johnson & Johnson
JNJ
+$6.77M

Sector Composition

Rank Sector Weight
1 Financials 17.55%
2 Technology 14.42%
3 Consumer Staples 13.81%
4 Communication Services 12.21%
5 Healthcare 10.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELGX
301
DELISTED
Endologix Inc
ELGX
$76K ﹤0.01%
1,700
-40
-2% -$1.82K
AAU
302
DELISTED
Almaden Minerals Ltd
AAU
$69K ﹤0.01%
60,000
FURY
303
Fury Gold Mines
FURY
$101M
$56K ﹤0.01%
+16,875
New +$64K
FSM icon
304
Fortuna Silver Mines
FSM
$2.61B
$48K ﹤0.01%
11,000
HMY icon
305
Harmony Gold Mining
HMY
$9.92B
$48K ﹤0.01%
26,500
GTE icon
306
Gran Tierra Energy
GTE
$257M
$43K ﹤0.01%
1,877
-8
-0.4% -$176
GALT icon
307
Galectin Therapeutics
GALT
$230M
$35K ﹤0.01%
16,400
SVM
308
Silvercorp Metals
SVM
$2.2B
$34K ﹤0.01%
12,500
NNVC icon
309
NanoViricides
NNVC
$34.9M
$32K ﹤0.01%
1,413
EGO icon
310
Eldorado Gold
EGO
$8.36B
$28K ﹤0.01%
2,530
NXE icon
311
NexGen Energy
NXE
$6.25B
$23K ﹤0.01%
10,500
GSS
312
DELISTED
Golden Star Resources Ltd.
GSS
$23K ﹤0.01%
6,000
URG
313
Ur-Energy
URG
$517M
$22K ﹤0.01%
38,000
UUUU icon
314
Energy Fuels
UUUU
$3.08B
$20K ﹤0.01%
12,500
DNN icon
315
Denison Mines
DNN
$2.76B
$18K ﹤0.01%
40,000
FWDI
316
Forward Industries Inc
FWDI
$319M
$18K ﹤0.01%
1,500
RCKT icon
317
Rocket Pharmaceuticals
RCKT
$360M
$18K ﹤0.01%
2,500
BAA
318
DELISTED
Banro Corporation Common Stock
BAA
$5K ﹤0.01%
15,000
-32,500
-68% -$14K
DXCM icon
319
DexCom
DXCM
$27.6B
-16,000
Closed -$293K
ORLY icon
320
O'Reilly Automotive
ORLY
$71.7B
-1,009,500
Closed -$14.7M
SHW icon
321
Sherwin-Williams
SHW
$78.9B
-210,600
Closed -$24.6M
SU icon
322
Suncor Energy
SU
$76.4B
-11,820
Closed -$345K
TRV icon
323
Travelers Companies
TRV
$82.1B
-1,620
Closed -$205K
TXN icon
324
Texas Instruments
TXN
$268B
-4,498
Closed -$346K
UYG icon
325
ProShares Ultra Financials
UYG
$803M
-7,590
Closed -$263K

Similar funds

Rathbones Group's Q3 2017 Portfolio in Review

As of Q3 2017, Rathbones Group held 334 positions worth $2.3B, up 2.3% from $2.24B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Rathbones Group's Q3 2017 filing shows 16 new, 94 increased, 96 reduced and 16 closed positions. Its largest new stake was DuPont de Nemours: 4,578 shares worth $803K. The largest sale was Sherwin-Williams, an estimated $24.6M.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Staples.

  • Rathbones Group's largest Q3 2017 buy was DuPont de Nemours: 4,578 shares worth $803K.
  • Rathbones Group added most to TJX Companies in Q3 2017, an estimated $5.77M increase.
  • Rathbones Group's biggest Q3 2017 reduction was Equifax, cutting an estimated $19.5M.
  • Rathbones Group fully exited Sherwin-Williams in Q3 2017, selling an estimated $24.6M.
  • Rathbones Group's ten largest holdings make up 28% of its $2.3B portfolio in Q3 2017.
  • Rathbones Group opened 16 new positions and closed 16 in Q3 2017.
  • Rathbones Group's portfolio value rose 2.3% quarter-over-quarter to $2.3B.

Based on Rathbones Group's 13F filing for Q3 2017, filed 24 Oct 2017.